Comparative analysis of adverse event risks in breast cancer patients receiving pembrolizumab combined with paclitaxel versus paclitaxel monotherapy: insights from the FAERS database
Article in Frontiers in Pharmacology (August 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (August 2024)
Article in International Journal of Molecular Sciences (June 2024)
Article in Future Journal of Pharmaceutical Sciences (March 2024)